$0.61 +0.08 (14.55%) Northwest Biotherapeutics Inc - NASDAQ

Sep. 26, 2016 | 04:00 PM
Last Trade: 0.61
Trade Time: Sep 26 04:00 PM Eastern Daylight Time
Change: +0.08 (14.55%)
Prev Close: 0.53
Open: 0.56
Bid: 0.61
Ask: 0.61
  1. No results found.
  1. Northwest Biotherapeutics Crashes On 3.5 Million Share Offering

    Benzinga | Dec. 23, 2015 | 14:06PM EST
  2. NW Bio Establishes Special Committee, Selects Law Firm to Conduct Independent Investigation of Recent Allegations

    Benzinga | Dec. 8, 2015 | 06:22AM EST
  3. NW Bio Enters Into Agreement For $30M Of New Equity Funding From Woodford Investment Management

    Benzinga | Oct. 21, 2015 | 12:04PM EST
  4. NW Bio Says Not Aware of Fundamental Reason for Friday's Decline in Pricr

    Benzinga | Oct. 19, 2015 | 10:02AM EST
  5. NW Bio Reports Release of New Data for Phase I Trial of DCVax-Direct: 27 of 39 Patients Still Alive at Up to 18 Months After First Injection

    Benzinga | Jun. 1, 2015 | 10:36AM EST
  6. Northwest Biotherapeutics Unit Completes $7.86M Purchase

    Benzinga | Dec. 15, 2014 | 17:13PM EST
  7. 5 Companies Developing New Cancer Drugs

    Benzinga | Aug. 19, 2014 | 13:20PM EST
  8. Northwest Biotherapeutics Shares Trading Sharply Lower

    Benzinga | Jul. 7, 2014 | 13:41PM EST
  9. Northwest Biotherapeutics In Recovery From Thursday Debacle?

    Benzinga | Jun. 20, 2014 | 10:32AM EST
  10. Mid-Day Market Movers For Thursday, June 19, 2014

    Benzinga | Jun. 19, 2014 | 15:04PM EST
  11. Mid-Day Market Movers For Monday, June 16, 2014

    Benzinga | Jun. 16, 2014 | 12:52PM EST
  12. Morning Market Movers

    Benzinga | Jun. 11, 2014 | 09:40AM EST
  13. Morning Movers for March 12th, 2014

    Benzinga | Mar. 12, 2014 | 10:15AM EST
  14. Afternoon Gainers for March 10th

    Benzinga | Mar. 10, 2014 | 15:17PM EST
  15. NW Biol Phase III GBM Brain Trial Is Subject Of BBC TV Report

    Benzinga | Dec. 30, 2013 | 08:19AM EST
Trading Center